Evidence map›Paper›PMID 26967145›Full record

ArticleJournal of visualized experiments : JoVE2016

Three-dimensional Biomimetic Technology: Novel Biorubber Creates Defined Micro- and Macro-scale Architectures in Collagen Hydrogels.

Veronica Rodriguez-Rivera, John W Weidner, Michael J Yost

Abstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Spatially and Temporally Controlled Hydrogels for Tissue Engineering.Materials science & engineering. R, Reports : a review journal · 2017
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Veronica Rodriguez-RiveraDepartment of Surgery - Division of General Surgery, Medical University of South Carolina.
John W WeidnerDepartment of Chemical Engineering, University of South Carolina.
Michael J YostDepartment of Surgery - Division of General Surgery, Medical University of South Carolina; yostm@musc.edu.

Funding

An Enabling Technology for Improving Engraftment of Implanted Materials and CellsR01DE019355 · NIDCR · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI YOST, MICHAEL J · 2010 to 2013
$1.4M
NIDCR NIH HHS IRO1DE019355NIDCR NIH HHS R01 DE019355
6 · The paper itself

Abstract

Tissue scaffolds play a crucial role in the tissue regeneration process. The ideal scaffold must fulfill several requirements such as having proper composition, targeted modulus, and well-defined architectural features. Biomaterials that recapitulate the intrinsic architecture of in vivo tissue are vital for studying diseases as well as to facilitate the regeneration of lost and malformed soft tissue. A novel biofabrication technique was developed which combines state of the art imaging, three-dimensional (3D) printing, and selective enzymatic activity to create a new generation of biomaterials for research and clinical application. The developed material, Bovine Serum Albumin rubber, is reaction injected into a mold that upholds specific geometrical features. This sacrificial material allows the adequate transfer of architectural features to a natural scaffold material. The prototype consists of a 3D collagen scaffold with 4 and 3 mm channels that represent a branched architecture. This paper emphasizes the use of this biofabrication technique for the generation of natural constructs. This protocol utilizes a computer-aided software (CAD) to manufacture a solid mold which will be reaction injected with BSA rubber followed by the enzymatic digestion of the rubber, leaving its architectural features within the scaffold material.

Indexed as

Printing, Three-DimensionalAnimalsBiocompatible MaterialsBiomimetic MaterialsCattleChemistry Techniques, SyntheticCollagenHydrogelsImaging, Three-DimensionalSerum AlbuminSoftwareTissue EngineeringTissue ScaffoldsBiocompatible MaterialsCollagenHydrogelsSerum Albumin

Identifiers

PMID26967145
PMCPMC4828153

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.